AI-enabled pathology Leverage PathAI Diagnostics’ integration of AI-powered pathology and end-to-end diagnostic capabilities to offer clients advanced, faster and more accurate pathology services, plus opportunities to expand AI-driven drug development support.

Specialized labs network Target gastroenterology, dermatology, oncology, urology and obstetrics/gynecology practices that already rely on GI Pathology, D-PATH Dermatopathology, Bostwick Laboratories and Women’s Health Laboratories for high-volume, board-certified pathology workflows.

Public sector & partners Capitalize on existing collaborations such as Memphis CARES/PARTNERS programs and school testing initiatives to position comprehensive COVID-19 testing and lab services as a broader, scalable health infrastructure offering for institutions and municipalities.

Digital workflow expansion Promote opportunities around digitizing laboratory workflows and cloud-enabled analytics by highlighting Cloudflare, Salesforce and other tech integrations already in use to streamline client onboarding, reporting, and AI model deployment for pharma and clinical research customers.

Growth through partnerships Emphasize potential for co-development with PathAI for AI-driven diagnostics, drug development support, and expanded pathology services to third-party clinics, CROs and health systems seeking differentiated, AI-enhanced solutions.